Bide Pharmaceutical: Net profit in 2025 is 152 million yuan, a year-on-year increase of 29.22%.

Bid Pharmaceuticals announces that in 2025, its operating income was 1.324 billion yuan, a year-on-year increase of 20.13%. Net profit was 152 million yuan, a year-on-year increase of 29.22%. The company plans to distribute a cash dividend of 11.6 yuan for every 10 shares to all shareholders based on a total share capital of 90.8829 million shares, with a total cash dividend of 99.9372 million yuan planned to be distributed, representing 65.86% of the net profit attributable to the company's shareholders for the year.